SEC Form 4 · accession 0001209191-16-141404
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Natalie Sacks
Officer — Chief Medical Officer
Period of report
Sep 12, 2016
Accepted (ET)
Sep 14, 2016 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 12, 2016 | A | 50,000 | $0.00 | A | 50,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $14.29 | Sep 12, 2016 | A | 250,000 | A | — | Sep 11, 2026 | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F1Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the vesting commencement date of August 31, 2016.
- F2The shares subject to the Option vest over a four-year period as follows: 25% of the shares vest on the one year anniversary of the vesting commencement date of August 31, 2016 and thereafter the remaining shares vest in a series of equal monthly installments at a rate of one thirty-sixth (1/36th) per month.